RRN10 Antibody

What is the RRN10 antibody and what cellular processes does it help investigate?

The RRN10 antibody is a research tool used to detect and analyze the Rrn10 protein, which is a component of the RNA Polymerase I Upstream Activation Factor (UAF) complex. This complex plays dual roles in activating RNA polymerase I (Pol I) transcription and repressing Pol II. The antibody helps investigate membrane trafficking, transcriptional regulation, and ribosomal DNA (rDNA) promoter activity. In research settings, the RRN10 antibody has been instrumental in detecting cross-linking intermediates between Rrn10 and other proteins such as histone H3, histone H4, Rrn5, and Rrn9, revealing important protein-protein interactions within the UAF complex .

How can I optimize Western blot protocols specifically for RRN10 antibody detection?

For optimal Western blot detection using RRN10 antibody:

• Sample preparation: Use fresh cell lysates from relevant organisms (particularly yeast if studying the native protein).

• Gel selection: Choose 10-12% polyacrylamide gels for optimal resolution of Rrn10.

• Transfer conditions: Transfer proteins to PVDF membranes at 100V for 1 hour in cold transfer buffer.

• Blocking: Block with 5% non-fat dry milk in TBST for 1 hour at room temperature.

• Primary antibody: Dilute RRN10 antibody 1:1000 in blocking solution and incubate overnight at 4°C.

• Washing: Wash membranes 3 times for 10 minutes each with TBST.

• Secondary antibody: Use appropriate HRP-conjugated secondary antibody at 1:5000 dilution.

• Development: Use enhanced chemiluminescence (ECL) for visualization.

When analyzing results, be aware that Rrn10 cross-linking intermediates with H3, H4, Rrn5, and Rrn9 can be detected by Western blotting after chemical cross-linking .

What are the most reliable positive and negative controls for RRN10 antibody experiments?

For reliable experimental controls when using RRN10 antibody:

Positive controls:

• Wild-type yeast expressing endogenous Rrn10

• Recombinant Rrn10 protein (partial or full-length)

• Cell lines with known Rrn10 expression

Negative controls:

• Rrn10 deletion mutant strains (Δrrn10)

• Irrelevant/non-targeting primary antibody of the same isotype

• Pre-immune serum (if using a polyclonal antibody)

• Peptide competition assay using the immunizing peptide

When evaluating antibody specificity, consider that even Rrn10 deletion variants are expressed in yeast at or below wild-type levels, as observed in studies with five different Rrn10 deletion variants . This means careful validation is required to distinguish between wild-type and variant forms.

How can cross-linking mass spectrometry (CXMS) with RRN10 antibody reveal UAF complex topology?

CXMS coupled with RRN10 antibody immunoprecipitation is a powerful approach for mapping complex protein interactions:

• Cross-linking procedure:

  • Treat purified UAF complex or cells with a chemical cross-linker (e.g., DSS or BS3)

  • Quench the reaction with appropriate buffer

  • Lyse cells if working with intact cells

• Immunoprecipitation:

  • Incubate lysate with RRN10 antibody

  • Capture antibody-antigen complexes with Protein A/G beads

  • Wash extensively to remove non-specific interactions

• Analysis of cross-linked complexes:

  • Resolve by SDS-PAGE

  • Perform Western blotting with antibodies against suspected interaction partners

  • For MS analysis, digest cross-linked proteins with trypsin

  • Identify cross-linked peptides by mass spectrometry

This approach has successfully revealed that the Rrn10 antibody can detect cross-linking intermediates where Rrn10 is linked to H3, H4, Rrn5, and Rrn9, providing insights into the molecular topology of the UAF complex .

What insights can domain-specific RRN10 antibodies provide about protein function in the UAF complex?

Domain-specific RRN10 antibodies can reveal functional insights by:

• Mapping functional domains:

  • N-terminal domain antibodies (residues 5-33): Can help study regions not essential for viability

  • Central domain antibodies: Target regions critical for UAF complex integrity

  • C-terminal domain antibodies: Focus on regions important for protein-protein interactions

• Protein-protein interaction analysis:

  • Epitope blocking experiments can identify which domains interact with other UAF components

  • Sequential immunoprecipitation using domain-specific antibodies can reveal topological arrangements

• Functional studies:

  • Correlate antibody binding to specific domains with functional outcomes

  • Compare antibody accessibility in wild-type versus deletion variants

Research has shown that deletions affecting the central half and the disordered C-terminal domain of Rrn10 result in severe slow-growth phenotypes, while N-terminal deletions have minimal impact. These regions cross-link to both Rrn9 and histone H3, indicating their importance for protein-protein interactions and association with UAF .

How can RRN10 antibody be used to investigate transcriptional switching between RNA polymerases?

The RRN10 antibody can provide insights into polymerase switching phenomena:

• Chromatin immunoprecipitation (ChIP) approach:

  • Cross-link proteins to DNA in wild-type and Rrn10-deficient cells

  • Immunoprecipitate with RRN10 antibody

  • Assess DNA enrichment at rDNA promoters and Pol I/Pol II occupancy

• Sequential ChIP analysis:

  • Perform initial ChIP with RRN10 antibody

  • Re-ChIP with antibodies against Pol I or Pol II components

  • Quantify co-occupancy patterns

• Correlation with transcriptional output:

  • Compare ChIP results with RNA analysis

  • Assess changes in rRNA versus mRNA production

This approach leverages findings that UAF acts as a Pol II barrier at the rDNA promoter, and disruption of UAF activity (including Rrn10 function) enables Pol II to transcribe rDNA, resulting in a polymerase switching phenotype .

How can I address weak or inconsistent signals when using RRN10 antibody?

To troubleshoot weak or inconsistent RRN10 antibody signals:

• Sample preparation improvements:

  • Ensure complete cell lysis with appropriate buffers

  • Add protease inhibitors to prevent degradation

  • Optimize protein extraction from nuclear fractions

  • Consider concentration steps for low-abundance samples

• Technical optimizations:

  • Increase antibody concentration (try 1:500 instead of 1:1000)

  • Extend primary antibody incubation time (up to 48 hours at 4°C)

  • Use signal enhancement systems (biotinylated secondary antibodies with streptavidin-HRP)

  • Try different detection substrates with higher sensitivity

• Protocol modifications:

  • Optimize blocking conditions to reduce background

  • Increase washing stringency if background is high

  • Decrease washing stringency if signal is lost

  • Consider membrane type (PVDF vs. nitrocellulose)

Remember that Rrn10 forms a complex network of interactions, and cross-linking studies show it interacts with multiple proteins , which might affect epitope accessibility in different experimental conditions.

What factors influence RRN10 antibody cross-reactivity with other proteins, and how can this be mitigated?

Factors influencing cross-reactivity and mitigation strategies:

When investigating UAF complex components, be aware that extensive cross-linking occurs between various subunits. For example, histone H3 and Rrn9 each cross-link to all five other UAF subunits, while Rrn10 only cross-links to H3 and Rrn9 . This interconnected network can complicate interpretation of results.

How should RRN10 antibody experimental designs account for different Rrn10 deletion variants?

When designing experiments with Rrn10 deletion variants:

• Antibody epitope considerations:

  • Ensure your RRN10 antibody's epitope is not within deleted regions

  • Use multiple antibodies targeting different regions when possible

  • Consider generating new antibodies for specific variant detection

• Experimental controls:

  • Include wild-type Rrn10 as positive control

  • Use Rrn10-null samples as negative control

  • Run side-by-side comparisons of all variants

• Phenotypic correlations:

  • Link antibody detection results with growth phenotypes

  • For N-terminal deletions (D1(5-14) and D2(5-33)): Expect near wild-type growth

  • For central/C-terminal deletions (D3 to D5): Anticipate severe slow-growth phenotypes

Studies have shown all five Rrn10 deletion variants are expressed in yeast at or below wild-type levels, with specific growth impacts correlating to the deleted regions .

How can I distinguish between direct and indirect interactions when using RRN10 antibody in co-immunoprecipitation experiments?

To distinguish between direct and indirect interactions:

• Sequential co-immunoprecipitation:

  • First IP with RRN10 antibody

  • Elute under mild conditions

  • Second IP with antibody against suspected interaction partner

  • Presence in final eluate suggests direct interaction

• Cross-linking distance analysis:

  • Use cross-linkers with different arm lengths

  • Short cross-linkers (~4-8Å) suggest direct interactions

  • Longer cross-linkers may capture indirect interactions

• Recombinant protein interaction assays:

  • Express Rrn10 and candidate interactors as recombinant proteins

  • Perform pull-downs in a defined system without other proteins

  • Confirm with surface plasmon resonance or similar techniques

• Deletion mutant analysis:

  • Create domain deletion mutants

  • Map which domains are required for specific interactions

Research has shown that Rrn10 cross-links directly to H3 and Rrn9, while showing fewer intermolecular cross-links than other UAF subunits, which suggests a more peripheral position in the complex .

What statistical approaches are most appropriate for analyzing RRN10 antibody immunoprecipitation mass spectrometry data?

For statistical analysis of IP-MS data:

• Enrichment analysis:

  • Calculate fold enrichment compared to control IPs

  • Apply t-tests or ANOVA for comparing conditions

  • Use Benjamini-Hochberg correction for multiple testing

• Probability-based scoring:

  • Implement SAINT (Significance Analysis of INTeractome) algorithm

  • Use CompPASS (Comparative Proteomics Analysis Software Suite)

  • Consider EPIC (Entropy-based Prioritization for Interacting Complexes)

• Network analysis:

  • Build interaction networks based on spectral counts

  • Calculate interaction stoichiometry

  • Perform cluster analysis to identify sub-complexes

• Visualization approaches:

  • Volcano plots (statistical significance vs. fold change)

  • Heat maps for comparing multiple conditions

  • Network diagrams weighted by interaction confidence

When analyzing UAF complex components, consider that histones H3 and H4, Rrn5, and Rrn9 form the core of the complex, while Rrn10 shows more limited interactions (primarily with H3 and Rrn9) .

How can contradictory findings between RRN10 antibody western blots and functional assays be reconciled?

To reconcile contradictory findings:

• Epitope accessibility assessment:

  • Determine if protein conformation affects antibody binding

  • Test multiple antibodies targeting different epitopes

  • Use denaturing vs. native conditions

• Post-translational modification analysis:

  • Check if modifications alter antibody recognition

  • Use phosphatase treatment to remove phosphorylations

  • Compare with antibodies specific to modified forms

• Protein complex context:

  • Determine if complex formation masks epitopes

  • Compare detection in isolated vs. complex-bound states

  • Use proximity ligation assays to confirm interactions

• Integrative interpretation framework:

  • Consider protein levels vs. activity levels

  • Assess temporal dynamics of interactions

  • Evaluate genetic background influences

Studies of Rrn10 deletion variants have shown that protein expression (detected by Western blot) doesn't always correlate with function, as some variants express at near wild-type levels but show severe growth defects, particularly those affecting the central and C-terminal regions that are important for interactions with Rrn9 and H3 .

How can super-resolution microscopy with RRN10 antibody advance our understanding of UAF complex spatial organization?

Super-resolution microscopy approaches with RRN10 antibody:

• STORM/PALM techniques:

  • Label Rrn10 with photoswitchable fluorophore-conjugated antibodies

  • Use dual-color imaging with other UAF components

  • Achieve 20-30nm resolution of complex organization

• Expansion microscopy:

  • Physically expand the sample after Rrn10 immunolabeling

  • Visualize previously unresolvable structural details

  • Combine with other UAF component labeling

• 3D reconstruction approaches:

  • Capture z-stacks of nucleolar regions

  • Create 3D renderings of UAF complex localization

  • Correlate with functional domains of the nucleolus

• Live-cell super-resolution:

  • Use cell-permeable nanobodies against Rrn10

  • Track dynamic changes during transcriptional activation/repression

  • Correlate with rDNA positioning

These approaches can build upon findings that UAF is not restricted to nucleolar sites of Pol I transcription but can also bind to the SIR2 locus to repress nuclear Pol II-dependent SIR2 transcription .

What role might RRN10 antibody-based approaches play in understanding epigenetic regulation of rDNA transcription?

RRN10 antibody-based approaches for studying epigenetic regulation:

• ChIP-seq for histone modification correlation:

  • Perform RRN10 antibody ChIP-seq

  • Compare with ChIP-seq for histone modifications (H3K4me3, H3K9me3, etc.)

  • Identify correlations between Rrn10 binding and chromatin states

• Sequential ChIP (Re-ChIP):

  • First ChIP with RRN10 antibody

  • Second ChIP with antibodies against epigenetic marks

  • Identify co-occurrence patterns

• Proximity-dependent labeling:

  • Use RRN10 antibody-guided APEX2 or BioID approaches

  • Identify proteins in proximity to Rrn10

  • Discover novel chromatin modifiers associated with UAF

• Long-read sequencing integration:

  • Combine RRN10 antibody ChIP with long-read sequencing

  • Map Rrn10 binding across repetitive rDNA regions

  • Correlate with epigenetic states

These approaches can expand on findings that UAF helps yeast cells maintain rDNA copy number through its dual Pol I-activating and Pol II-repressive functions .